Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 97-101

  Bekelman, Justin E ^a,c   Suneja, Gita ^a   Guzzo, Thomas ^a,b   Pollack, Craig Evan ^c,e   Armstrong, Katrina ^a,c   Epstein, Andrew J ^a,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

delivery of health care, integrated; physician's practice patterns; prostate; prostatic neoplasms; radiotherapy, intensity modulated

Indexed keywords

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER THERAPY; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICARE; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION ONCLOGIST; REIMBURSEMENT; SOCIOECONOMICS; UROLOGIST;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CANCER CARE FACILITIES; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE, INTEGRATED; DISEASE-FREE SURVIVAL; GROUP PRACTICE; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF HEALTH CARE; RADIATION ONCOLOGY; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UROLOGY;

EID: 84878891389     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.103     Document Type: Article

References (25)

1. K.R. Yabroff, E.B. Lamont, A. Mariotto Cost of care for elderly cancer patients in the United States J Natl Cancer Inst 100 2008 630
2. A. Mariotto, K. Yabroff, Y. Shao Projections of the cost of cancer care in the United States: 2010-2020 J Natl Cancer Inst 103 2011 117
3. D. Leonhardt Economic Scene: In Health Reform, a Cancer Offers an Acid Test July 7, 2009 The New York Times
4. P.L. Nguyen, X. Gu, S.R. Lipsitz Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517
5. C. Bolenz, A. Gupta, T. Hotze Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer Eur Urol 57 2010 453
6. D.A. Ollendorf, J. Hayes, P. McMahon Management Options for Low-Risk Prostate Cancer: A Report on Comparative Effectiveness and Value 2009 Institute for Clinical and Economic Review Boston www.icer-review.org Accessed January 5, 2011
7. J. Carreyrou, M. Tamman Health Industry: A Device to Kill Cancer, Lift Revenue December 7, 2010 The Wall Street Journal http://online.wsj.com/article/ SB10001424052748703904804575631222900534954.html Accessed January 3, 2011
8. S. Saul Side Effects: Profit and Questions on Prostate Cancer Therapy December 1, 2006 The New York Times
9. D.A. Kapoor, S.H. Zimberg, L.M. Ohrin Utilization trends in prostate cancer therapy J Urol 186 2011 860
10. B.P. Falit, C.P. Gross, K.B. Roberts Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology Int J Radiat Oncol Biol Phys 76 2010 1285
11. A. Winter Services provided under the in-office ancillary exception to the physician self-referral law Presented at Medicare Payment Advisory Commission Public Meeting, March 4 and 5, 2010, p 223 http://www.medpac.gov/ transcripts/0304-05MedPAC.final.pdf Accessed December 1, 2011
12. H. Waxman, S. Levin, P. Stark Letter Washington, D.C.: Congress of the United States http://www.auanet.org/content/media/Congressional%20Request- GAO%20Study-Imaging%20.pdf Accessed December 1, 2011
13. B. Hollenbeck, B. Nallamothu Financial incentives and the art of payment reform JAMA 306 2011 2028
14. J.M. Mitchell, J.H. Sunshine Consequences of physicians' ownership of health care facilities-joint ventures in radiation therapy N Engl J Med 327 1992 1497
15. Report to Congressional Requesters: Higher Use of Advanced Imaging Services by Providers Who Self-Refer Costing Medicare Millions 2012 United States Government Accountability Office Washington, D.C. http://democrats. energycommerce.house.gov/sites/default/files/documents/GAO-Medicare-Self-Refer- Report-2012-10-31.pdf Accessed January 22, 2013
16. V.B. Shahinian, Y.F. Kuo, S.M. Gilbert Reimbursement policy and androgen-deprivation therapy for prostate cancer N Engl J Med 363 2010 1822
17. J. Wennberg, A. Gittelsohn Small area variations in health care delivery Science 182 1973 1102
18. S.D. Swisher-McClure, R. Sunderland, J. Christodouleas Variation in use of androgen suppression with external beam radiotherapy for non-metastatic prostate cancer Int J Radiat Oncol Biol Phys 83 2012 8
19. A. Elixhauser, C. Steiner, D. Harris Comorbidity measures for use with administrative data Med Care 36 1998 8
20. NCCN Clinical Practice Guidelines in Oncology (NCCN Guideline) Prostate Cancer. Version 2.2011 2011 National Comprehensive Cancer Network Ft. Washington, Pennsylvania
21. J. Wooldridge Econometric Analysis of Cross Section and Panel Data 2nd ed. 2010 MIT Press Cambridge, Massachusetts
22. L. Kleinman, E. Norton What's the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression Health Serv Research 44 2009 288
23. R. Berenson, T. Bodenheimer, H. Pham Specialty-service lines: salvos in the new medical arms race Health Affairs 25 2006 w337
24. R. Huckman, G. Pisano Turf battles in coronary revascularization N Engl J Med 352 2005 857
25. B.L. Jacobs, Y. Zhang, T.A. Skolarus Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse Health Aff (Millwood) 31 2012 750